NY Legalized Marijuana, But Safety and Health Concerns Remain
New York's cannabis legalization presents significant challenges in clinical practice, especially regarding patient safety protocols. Healthcare providers face gaps in dosing guidance and regulatory oversight. Addressing new york cannabis legalization…
Navigating Cannabis and Cannabinoid Use in Today’s Clinical Practice – YouTube
Cannabis clinical education resources are vital as more clinicians encounter patients using cannabinoids therapeutically. These resources help bridge the gap between patient use and evidence-based guidance. Quality clinical education supports informed…
Jail for Slough drug dealer caught with over £60k of heroin, cocaine and cannabis
This article discusses the legal conflation cannabis heroin cocaine in a Slough drug dealer case. The conflation perpetuates stigma affecting patient communication about cannabis. Understanding this issue is vital for clinical practice and legal…
Study Reveals Gender Differences in Cannabis Metabolism and Use
This study highlights gender differences cannabis metabolism affecting medical marijuana use. Understanding these differences is crucial for tailored therapeutic approaches. Clinicians should consider gender-specific factors when recommending cannabis…
United States Cannabis Policy Evolves with Federal Regulatory Changes
The federal cannabis regulatory framework is undergoing significant changes with ongoing policy evolution. Reclassification efforts could reshape clinical research and prescribing authority. This impacts clinicians and patients across the United States.
(THC) as a Liquidity Pulse for Institutional Tactics – Stock Traders Daily
This article explores the concept of thc liquidity pulse institutional tactics in stock market trading. It clarifies that THC here refers to a stock ticker symbol, not cannabis medicine. Understanding these tactics is crucial for distinguishing financial…
Trump Complains DOJ Is ‘Slow-Walking’ Marijuana Rescheduling, Four Months After He Issued Order
Marijuana rescheduling delays continue to affect clinical practice and research opportunities. The federal cannabis policy update remains uncertain, impacting prescribing protocols. Clinicians must monitor these regulatory changes closely to adapt…
Forbes Daily: The Cannabis Industry’s High Hopes For Federal Reform
Cannabis federal reform is poised to transform clinical practice by standardizing product quality and expanding patient access across states. This reform could enable physicians to prescribe cannabis therapeutics rather than merely recommend them. The…
Boy Drowns in Anacostia River, Fairfax Murder-Suicide, Cannabis Setback
This article discusses a legal cannabis setback and its clinical relevance. Cannabis policy changes can affect patient access and regulatory frameworks. Clinicians should monitor these developments closely.
Who Is Recommending Medical Cannabis—and What Are They Telling Patients?
A 2019 survey highlights medical cannabis clinical practice patterns among providers, showing wide variation in education and dosing. This study reveals a self-generated community standard without formal guidelines. Understanding these patterns is key to…